
ANI Pharmaceuticals ANIP
$ 73.59
2.05%
ANI Pharmaceuticals EV/EBITDA Ratio | ANIP
Annual EV/EBITDA Ratio ANI Pharmaceuticals
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9.16 | 27.9 | 13.4 | 49.5 | 109 | 17.9 | 13.9 | 11.2 | 16.6 | 15.5 | 8.15 | 23.2 | 47.8 | -0.202 | -0.474 | -57.4 | 3.02 K | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 3.02 K | -57.4 | 195 |
EV/EBITDA Ratio of other stocks in the Biotechnology industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Aclaris Therapeutics
ACRS
|
-5.56 | $ 5.32 | 0.09 % | $ 652 M | ||
|
ADC Therapeutics SA
ADCT
|
-3.2 | $ 1.05 | 0.46 % | $ 133 M | ||
|
Agenus
AGEN
|
-9.32 | $ 7.21 | 0.7 % | $ 214 M | ||
|
Фармсинтез
LIFE
|
-115 | - | - | - | ||
|
Akebia Therapeutics
AKBA
|
19.9 | $ 0.92 | 1.64 % | $ 237 M | ||
|
Alector
ALEC
|
-2.95 | $ 1.93 | 0.81 % | $ 199 M | ||
|
Amryt Pharma plc
AMYT
|
-75 | - | - | $ 621 M | ||
|
Aligos Therapeutics
ALGS
|
-0.949 | $ 5.05 | 1.2 % | $ 49.9 M | ||
|
Alkermes plc
ALKS
|
19.2 | $ 46.07 | 0.09 % | $ 7.59 B | ||
|
Allogene Therapeutics
ALLO
|
-3.13 | $ 1.69 | 0.58 % | $ 373 M | ||
|
Alnylam Pharmaceuticals
ALNY
|
77.8 | $ 239.36 | 0.46 % | $ 31.4 B | ||
|
Altimmune
ALT
|
-3.49 | $ 3.24 | 0.31 % | $ 285 M | ||
|
ALX Oncology Holdings
ALXO
|
-1.27 | $ 1.76 | 0.53 % | $ 94.4 M | ||
|
Evelo Biosciences
EVLO
|
-0.456 | - | -14.46 % | $ 27.9 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
11.2 | $ 23.95 | 1.31 % | $ 1.12 B | ||
|
AnaptysBio
ANAB
|
26.4 | $ 54.31 | 0.15 % | $ 1.56 B | ||
|
Anika Therapeutics
ANIK
|
-27.5 | $ 20.84 | 0.24 % | $ 299 M | ||
|
Aptevo Therapeutics
APVO
|
0.398 | $ 1.72 | 0.58 % | $ 543 K | ||
|
Allakos
ALLK
|
-0.000271 | - | - | $ 28.6 M | ||
|
Aquestive Therapeutics
AQST
|
-7.66 | $ 4.82 | 0.21 % | $ 515 M | ||
|
Arcturus Therapeutics Holdings
ARCT
|
-0.593 | $ 15.6 | 0.25 % | $ 427 M | ||
|
Armata Pharmaceuticals
ARMP
|
-17.1 | $ 4.07 | 2.21 % | $ 147 M | ||
|
Assembly Biosciences
ASMB
|
-25.1 | $ 25.48 | 0.54 % | $ 286 M | ||
|
Actinium Pharmaceuticals
ATNM
|
-0.744 | $ 1.24 | 0.79 % | $ 38.7 M | ||
|
AbbVie
ABBV
|
24.9 | $ 262.51 | 0.01 % | $ 464 B | ||
|
Atara Biotherapeutics
ATRA
|
3.26 | $ 10.11 | 7.1 % | $ 127 M | ||
|
Aurinia Pharmaceuticals
AUPH
|
37 | $ 16.96 | 5.15 % | $ 2.28 B | ||
|
Autolus Therapeutics plc
AUTL
|
-2.4 | $ 1.87 | 0.53 % | $ 498 M | ||
|
Atea Pharmaceuticals
AVIR
|
-2.05 | $ 5.15 | 1.24 % | $ 420 M | ||
|
Axon Enterprise
AXON
|
1.57 K | $ 468.42 | 5.96 % | $ 36.6 B | ||
|
Axsome Therapeutics
AXSM
|
-53.8 | $ 211.97 | 3.87 % | $ 10.5 B | ||
|
Aytu BioScience
AYTU
|
6.2 | $ 1.97 | 0.5 % | $ 12.4 M | ||
|
BridgeBio Pharma
BBIO
|
-30 | $ 68.3 | 0.1 % | $ 13.1 B | ||
|
Bicycle Therapeutics plc
BCYC
|
0.703 | $ 3.64 | 0.68 % | $ 252 M | ||
|
Black Diamond Therapeutics
BDTX
|
10.5 | $ 1.94 | 1.02 % | $ 110 M | ||
|
Beam Therapeutics
BEAM
|
-8.71 | $ 23.1 | 0.15 % | $ 2.28 B | ||
|
Biogen
BIIB
|
48.2 | $ 216.01 | 0.42 % | $ 31.6 B | ||
|
BioLineRx Ltd.
BLRX
|
-550 | $ 2.48 | 0.79 % | $ 6.11 B | ||
|
AbCellera Biologics
ABCL
|
-6.16 | $ 11.67 | 2.28 % | $ 3.49 B | ||
|
Benitec Biopharma
BNTC
|
-7.59 | $ 11.04 | 0.9 % | $ 514 M | ||
|
Checkmate Pharmaceuticals
CMPI
|
-0.186 | - | - | $ 231 M | ||
|
Burford Capital Limited
BUR
|
24.7 | $ 3.87 | 0.8 % | $ 848 M | ||
|
Clovis Oncology
CLVS
|
-19.7 | - | -7.23 % | $ 13 M | ||
|
Chimerix
CMRX
|
0.0697 | - | - | $ 756 M | ||
|
Concert Pharmaceuticals
CNCE
|
-0.207 | - | - | $ 401 M | ||
|
Cabaletta Bio
CABA
|
-1.49 | $ 2.49 | 0.39 % | $ 250 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
0.0726 | $ 2.24 | 0.89 % | $ 3.69 M | ||
|
Catalyst Biosciences
CBIO
|
70.6 | $ 17.18 | 1.7 % | $ 1.53 B | ||
|
C4 Therapeutics
CCCC
|
-2.31 | $ 3.45 | 0.58 % | $ 286 M |